$0.03
(Market cap
$31 Mln
Recently Viewed
Clear AllMarket cap
$31 Mln
Revenue (TTM)
$19 Mln
P/E Ratio
26.1
P/B Ratio
3
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
19.2
Debt to Equity
0.1
Book Value
$0.9
EPS
$0.1
Face value
--
Shares outstanding
10,644,268
CFO
$-25.16 Mln
EBITDA
$-30.31 Mln
Net Profit
$-38.67 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nephros (NEPH)
| -41.2 | -7.7 | -38.7 | 54.3 | 26.7 | -18.1 | 0.0 |
|
BSE Sensex
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Nephros (NEPH)
| 232.0 | -57.2 | 199.0 | -80.3 | -31.2 | -13.8 | 94.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nephros (NEPH)
|
2.9 | 30.6 | 18.8 | 1.2 | 6.1 | 12.7 | 26.1 | 3.0 |
| 0.1 | 46.4 | 0.0 | -2.9 | -- | 87.7 | -- | 67.5 | |
| 80.2 | 5,100.9 | 1,836.8 | 7.9 | 3.9 | 0.5 | 668.3 | 3.3 | |
| 1.4 | 42.1 | 26.7 | -2.3 | -12.7 | -5.7 | -- | 1.0 | |
| 2.1 | 21.1 | 16.5 | -8.5 | -45.0 | -63 | -- | 2.0 | |
| 21.2 | 756.0 | 830.5 | -0.8 | 3.7 | -0.2 | -- | 1.7 | |
| 12.7 | 235.4 | 61.7 | -13.8 | -18.1 | -24.5 | -- | 4.7 | |
| 1.1 | 23.9 | 250.2 | -15.4 | -0.1 | -32.5 | -- | 0.6 | |
| 31.2 | 8,147.6 | 4,797.5 | 352.2 | 13.0 | 19.6 | 23.5 | 4.4 | |
| 2.2 | 662.5 | 88.1 | -158.6 | -87.0 | -289.7 | -- | 0.1 |
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological... contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. Read more
President, CEO & Director
Mr. Robert Banks
President, CEO & Director
Mr. Robert Banks
Headquarters
South Orange, NJ
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Nephros Inc (NEPH) is $2.87 (NASDAQ) as of 24-Apr-2026 16:00 EDT. Nephros Inc (NEPH) has given a return of 26.73% in the last 3 years.
The P/E ratio of Nephros Inc (NEPH) is 26.09 times as on 24-Apr-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
44.83
|
5.25
|
|
2024
|
209.69
|
1.81
|
|
2023
|
-23.16
|
4.36
|
|
2022
|
-1.61
|
2.13
|
|
2021
|
-14.43
|
5.07
|
The 52-week high and low of Nephros Inc (NEPH) are Rs 6.42 and Rs 1.64 as of 26-Apr-2026.
Nephros Inc (NEPH) has a market capitalisation of $ 31 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Nephros Inc (NEPH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.